Perbedaan Archi Indonesia Tbk dan Diagnos Laboratorium Utama Tbk.: Archi Indonesia Tbk diperdagangkan di Rp1.200 (kapitalisasi pasar 31,42 T, volume 24 jam 23,62 jt), sedangkan Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp232 (kapitalisasi pasar 316,25 M, volume 24 jam 41,7 rb). Perbedaan utamanya: Archi Indonesia Tbk jauh lebih besar — sekitar 99,4× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Archi Indonesia Tbk lebih aktif diperdagangkan (23,62 jt vs 41,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ARCI | DGNS | |
|---|---|---|
Kapitalisasi Pasar | 31,42 T | 316,25 M |
Volume | 23,62 jt | 41,7 rb |
Lot | 236,18 rb | 417 |
Perputaran | 28,62 M | 9,66 jt |
Harga Rata-rata | 1.211,87 | 231,65 |
Nilai Transaksi | 28,62 M | 9,66 jt |
Harga Ekuilibrium Indikatif | 1.200 | 230 |
Volume Ekuilibrium Indikatif | 6,49 rb | 2,4 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Archi Indonesia Tbk. (the Company) was established based on Notarial Deed No. 1 of Fatma Agung Budiwijaya, S.H., dated September 14, 2010. The Company commenced its commercial operations in 2010 and is primarily involved in investment holding. PT Rajawali Corpora is the Companys parent and ultimate parent entity.
Selengkapnya di halaman ARCI →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →